nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—SULT1E1—gonad—ovarian cancer	0.0436	0.149	CbGeAlD
Cyclizine—SULT1E1—female reproductive system—ovarian cancer	0.0389	0.134	CbGeAlD
Cyclizine—SULT1E1—female gonad—ovarian cancer	0.0354	0.121	CbGeAlD
Cyclizine—SULT1E1—vagina—ovarian cancer	0.0352	0.121	CbGeAlD
Cyclizine—SULT1E1—testis—ovarian cancer	0.0314	0.108	CbGeAlD
Cyclizine—SULT1E1—lymph node—ovarian cancer	0.0228	0.0781	CbGeAlD
Cyclizine—Convulsion—Altretamine—ovarian cancer	0.0146	0.0207	CcSEcCtD
Cyclizine—Dyskinesia—Chlorambucil—ovarian cancer	0.0146	0.0206	CcSEcCtD
Cyclizine—Blister—Vinorelbine—ovarian cancer	0.0145	0.0205	CcSEcCtD
Cyclizine—Muscle twitching—Chlorambucil—ovarian cancer	0.014	0.0198	CcSEcCtD
Cyclizine—HRH1—myometrium—ovarian cancer	0.0119	0.0409	CbGeAlD
Cyclizine—Injection site reaction—Melphalan—ovarian cancer	0.0119	0.0168	CcSEcCtD
Cyclizine—Injection site reaction—Vinorelbine—ovarian cancer	0.0104	0.0147	CcSEcCtD
Cyclizine—Asthenia—Altretamine—ovarian cancer	0.0099	0.014	CcSEcCtD
Cyclizine—HRH1—epithelium—ovarian cancer	0.00936	0.0321	CbGeAlD
Cyclizine—Dermatitis bullous—Topotecan—ovarian cancer	0.00929	0.0131	CcSEcCtD
Cyclizine—HRH1—uterine cervix—ovarian cancer	0.00928	0.0319	CbGeAlD
Cyclizine—Dizziness—Altretamine—ovarian cancer	0.00912	0.0129	CcSEcCtD
Cyclizine—HRH1—decidua—ovarian cancer	0.00885	0.0304	CbGeAlD
Cyclizine—Thrombophlebitis—Vinorelbine—ovarian cancer	0.00878	0.0124	CcSEcCtD
Cyclizine—HRH1—endometrium—ovarian cancer	0.0084	0.0288	CbGeAlD
Cyclizine—Pain—Carboplatin—ovarian cancer	0.00815	0.0115	CcSEcCtD
Cyclizine—Dermatitis bullous—Vinorelbine—ovarian cancer	0.00795	0.0112	CcSEcCtD
Cyclizine—Dyskinesia—Paclitaxel—ovarian cancer	0.00749	0.0106	CcSEcCtD
Cyclizine—Bronchospasm—Melphalan—ovarian cancer	0.00739	0.0104	CcSEcCtD
Cyclizine—CYP2C9—female reproductive system—ovarian cancer	0.00705	0.0242	CbGeAlD
Cyclizine—Injection site reaction—Paclitaxel—ovarian cancer	0.007	0.00988	CcSEcCtD
Cyclizine—HRH1—female reproductive system—ovarian cancer	0.00696	0.0239	CbGeAlD
Cyclizine—Hepatobiliary disease—Topotecan—ovarian cancer	0.00647	0.00914	CcSEcCtD
Cyclizine—Bronchospasm—Vinorelbine—ovarian cancer	0.00646	0.00912	CcSEcCtD
Cyclizine—Hepatobiliary disease—Melphalan—ovarian cancer	0.00634	0.00895	CcSEcCtD
Cyclizine—HRH1—female gonad—ovarian cancer	0.00633	0.0217	CbGeAlD
Cyclizine—HRH1—vagina—ovarian cancer	0.00629	0.0216	CbGeAlD
Cyclizine—Hepatitis—Melphalan—ovarian cancer	0.00602	0.00849	CcSEcCtD
Cyclizine—Injection site reaction—Docetaxel—ovarian cancer	0.00593	0.00837	CcSEcCtD
Cyclizine—Connective tissue disorder—Melphalan—ovarian cancer	0.00591	0.00834	CcSEcCtD
Cyclizine—Thrombophlebitis—Paclitaxel—ovarian cancer	0.0059	0.00833	CcSEcCtD
Cyclizine—Tremor—Chlorambucil—ovarian cancer	0.00563	0.00794	CcSEcCtD
Cyclizine—HRH1—testis—ovarian cancer	0.00561	0.0193	CbGeAlD
Cyclizine—Blister—Epirubicin—ovarian cancer	0.00558	0.00788	CcSEcCtD
Cyclizine—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.00554	0.00781	CcSEcCtD
Cyclizine—Agitation—Chlorambucil—ovarian cancer	0.00552	0.00779	CcSEcCtD
Cyclizine—Chills—Topotecan—ovarian cancer	0.00551	0.00778	CcSEcCtD
Cyclizine—Angioedema—Chlorambucil—ovarian cancer	0.00549	0.00775	CcSEcCtD
Cyclizine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00546	0.00771	CcSEcCtD
Cyclizine—Convulsion—Chlorambucil—ovarian cancer	0.0052	0.00735	CcSEcCtD
Cyclizine—Blister—Doxorubicin—ovarian cancer	0.00517	0.00729	CcSEcCtD
Cyclizine—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00516	0.00729	CcSEcCtD
Cyclizine—Muscle spasms—Topotecan—ovarian cancer	0.00514	0.00726	CcSEcCtD
Cyclizine—Thrombophlebitis—Docetaxel—ovarian cancer	0.005	0.00706	CcSEcCtD
Cyclizine—Angioedema—Topotecan—ovarian cancer	0.00489	0.0069	CcSEcCtD
Cyclizine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00458	0.00646	CcSEcCtD
Cyclizine—Erythema—Vinorelbine—ovarian cancer	0.00457	0.00646	CcSEcCtD
Cyclizine—Convulsion—Melphalan—ovarian cancer	0.00454	0.0064	CcSEcCtD
Cyclizine—Dermatitis bullous—Docetaxel—ovarian cancer	0.00453	0.0064	CcSEcCtD
Cyclizine—Anaphylactic shock—Topotecan—ovarian cancer	0.00436	0.00616	CcSEcCtD
Cyclizine—Dyskinesia—Epirubicin—ovarian cancer	0.00428	0.00604	CcSEcCtD
Cyclizine—Nervous system disorder—Topotecan—ovarian cancer	0.00428	0.00604	CcSEcCtD
Cyclizine—Anaphylactic shock—Melphalan—ovarian cancer	0.00427	0.00603	CcSEcCtD
Cyclizine—Skin disorder—Topotecan—ovarian cancer	0.00424	0.00598	CcSEcCtD
Cyclizine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00424	0.00598	CcSEcCtD
Cyclizine—Pain—Chlorambucil—ovarian cancer	0.00419	0.00592	CcSEcCtD
Cyclizine—Angioedema—Vinorelbine—ovarian cancer	0.00418	0.0059	CcSEcCtD
Cyclizine—Tachycardia—Melphalan—ovarian cancer	0.00417	0.00589	CcSEcCtD
Cyclizine—Skin disorder—Melphalan—ovarian cancer	0.00415	0.00586	CcSEcCtD
Cyclizine—HRH1—lymph node—ovarian cancer	0.00407	0.014	CbGeAlD
Cyclizine—Injection site reaction—Epirubicin—ovarian cancer	0.004	0.00565	CcSEcCtD
Cyclizine—Hypotension—Melphalan—ovarian cancer	0.00399	0.00564	CcSEcCtD
Cyclizine—Dyskinesia—Doxorubicin—ovarian cancer	0.00396	0.00559	CcSEcCtD
Cyclizine—Hypertension—Vinorelbine—ovarian cancer	0.00395	0.00557	CcSEcCtD
Cyclizine—Paraesthesia—Topotecan—ovarian cancer	0.00392	0.00553	CcSEcCtD
Cyclizine—Urticaria—Chlorambucil—ovarian cancer	0.00389	0.0055	CcSEcCtD
Cyclizine—Paraesthesia—Melphalan—ovarian cancer	0.00384	0.00542	CcSEcCtD
Cyclizine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00373	0.00527	CcSEcCtD
Cyclizine—Constipation—Topotecan—ovarian cancer	0.00373	0.00527	CcSEcCtD
Cyclizine—Pain—Topotecan—ovarian cancer	0.00373	0.00527	CcSEcCtD
Cyclizine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00372	0.00526	CcSEcCtD
Cyclizine—Injection site reaction—Doxorubicin—ovarian cancer	0.0037	0.00522	CcSEcCtD
Cyclizine—Bronchospasm—Docetaxel—ovarian cancer	0.00368	0.0052	CcSEcCtD
Cyclizine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00366	0.00517	CcSEcCtD
Cyclizine—Pain—Melphalan—ovarian cancer	0.00365	0.00516	CcSEcCtD
Cyclizine—Tachycardia—Vinorelbine—ovarian cancer	0.00364	0.00514	CcSEcCtD
Cyclizine—Skin disorder—Vinorelbine—ovarian cancer	0.00363	0.00512	CcSEcCtD
Cyclizine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00361	0.0051	CcSEcCtD
Cyclizine—Asthenia—Chlorambucil—ovarian cancer	0.00352	0.00497	CcSEcCtD
Cyclizine—Hypotension—Vinorelbine—ovarian cancer	0.00349	0.00492	CcSEcCtD
Cyclizine—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00347	0.0049	CcSEcCtD
Cyclizine—Pruritus—Chlorambucil—ovarian cancer	0.00347	0.0049	CcSEcCtD
Cyclizine—Urticaria—Topotecan—ovarian cancer	0.00347	0.00489	CcSEcCtD
Cyclizine—Urticaria—Melphalan—ovarian cancer	0.0034	0.00479	CcSEcCtD
Cyclizine—Thrombophlebitis—Epirubicin—ovarian cancer	0.00337	0.00476	CcSEcCtD
Cyclizine—Paraesthesia—Vinorelbine—ovarian cancer	0.00335	0.00473	CcSEcCtD
Cyclizine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00334	0.00472	CcSEcCtD
Cyclizine—Eye disorder—Paclitaxel—ovarian cancer	0.0033	0.00466	CcSEcCtD
Cyclizine—Hypersensitivity—Topotecan—ovarian cancer	0.00322	0.00454	CcSEcCtD
Cyclizine—Pain—Vinorelbine—ovarian cancer	0.00319	0.00451	CcSEcCtD
Cyclizine—Constipation—Vinorelbine—ovarian cancer	0.00319	0.00451	CcSEcCtD
Cyclizine—Chills—Paclitaxel—ovarian cancer	0.00317	0.00448	CcSEcCtD
Cyclizine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00316	0.00446	CcSEcCtD
Cyclizine—Hypersensitivity—Melphalan—ovarian cancer	0.00315	0.00444	CcSEcCtD
Cyclizine—Asthenia—Topotecan—ovarian cancer	0.00313	0.00442	CcSEcCtD
Cyclizine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00312	0.00441	CcSEcCtD
Cyclizine—Agranulocytosis—Docetaxel—ovarian cancer	0.00311	0.0044	CcSEcCtD
Cyclizine—Mental disorder—Paclitaxel—ovarian cancer	0.0031	0.00437	CcSEcCtD
Cyclizine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00309	0.00437	CcSEcCtD
Cyclizine—Pruritus—Topotecan—ovarian cancer	0.00309	0.00436	CcSEcCtD
Cyclizine—Erythema—Paclitaxel—ovarian cancer	0.00308	0.00434	CcSEcCtD
Cyclizine—Asthenia—Melphalan—ovarian cancer	0.00307	0.00433	CcSEcCtD
Cyclizine—Dermatitis bullous—Epirubicin—ovarian cancer	0.00306	0.00431	CcSEcCtD
Cyclizine—Pruritus—Melphalan—ovarian cancer	0.00302	0.00427	CcSEcCtD
Cyclizine—Tension—Paclitaxel—ovarian cancer	0.00302	0.00426	CcSEcCtD
Cyclizine—Hepatitis—Docetaxel—ovarian cancer	0.003	0.00423	CcSEcCtD
Cyclizine—Nervousness—Paclitaxel—ovarian cancer	0.00299	0.00422	CcSEcCtD
Cyclizine—Urticaria—Vinorelbine—ovarian cancer	0.00297	0.00419	CcSEcCtD
Cyclizine—Muscle spasms—Paclitaxel—ovarian cancer	0.00296	0.00418	CcSEcCtD
Cyclizine—Connective tissue disorder—Docetaxel—ovarian cancer	0.00294	0.00416	CcSEcCtD
Cyclizine—Vision blurred—Paclitaxel—ovarian cancer	0.0029	0.00409	CcSEcCtD
Cyclizine—Dizziness—Topotecan—ovarian cancer	0.00289	0.00407	CcSEcCtD
Cyclizine—Tremor—Paclitaxel—ovarian cancer	0.00288	0.00407	CcSEcCtD
Cyclizine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00283	0.00399	CcSEcCtD
Cyclizine—Agitation—Paclitaxel—ovarian cancer	0.00283	0.00399	CcSEcCtD
Cyclizine—Angioedema—Paclitaxel—ovarian cancer	0.00281	0.00397	CcSEcCtD
Cyclizine—Eye disorder—Docetaxel—ovarian cancer	0.0028	0.00395	CcSEcCtD
Cyclizine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00275	0.00388	CcSEcCtD
Cyclizine—Headache—Topotecan—ovarian cancer	0.00273	0.00386	CcSEcCtD
Cyclizine—Chills—Docetaxel—ovarian cancer	0.00269	0.00379	CcSEcCtD
Cyclizine—Asthenia—Vinorelbine—ovarian cancer	0.00268	0.00378	CcSEcCtD
Cyclizine—Convulsion—Paclitaxel—ovarian cancer	0.00267	0.00376	CcSEcCtD
Cyclizine—Hypertension—Paclitaxel—ovarian cancer	0.00266	0.00375	CcSEcCtD
Cyclizine—Pruritus—Vinorelbine—ovarian cancer	0.00264	0.00373	CcSEcCtD
Cyclizine—Mental disorder—Docetaxel—ovarian cancer	0.00262	0.0037	CcSEcCtD
Cyclizine—Erythema—Docetaxel—ovarian cancer	0.00261	0.00368	CcSEcCtD
Cyclizine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00251	0.00354	CcSEcCtD
Cyclizine—Muscle spasms—Docetaxel—ovarian cancer	0.00251	0.00354	CcSEcCtD
Cyclizine—Dizziness—Vinorelbine—ovarian cancer	0.00247	0.00348	CcSEcCtD
Cyclizine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00246	0.00348	CcSEcCtD
Cyclizine—Tachycardia—Paclitaxel—ovarian cancer	0.00245	0.00346	CcSEcCtD
Cyclizine—Skin disorder—Paclitaxel—ovarian cancer	0.00244	0.00344	CcSEcCtD
Cyclizine—Hypotension—Paclitaxel—ovarian cancer	0.00235	0.00331	CcSEcCtD
Cyclizine—Headache—Vinorelbine—ovarian cancer	0.00234	0.0033	CcSEcCtD
Cyclizine—Insomnia—Paclitaxel—ovarian cancer	0.00227	0.00321	CcSEcCtD
Cyclizine—Convulsion—Docetaxel—ovarian cancer	0.00226	0.00319	CcSEcCtD
Cyclizine—Paraesthesia—Paclitaxel—ovarian cancer	0.00226	0.00318	CcSEcCtD
Cyclizine—Hypertension—Docetaxel—ovarian cancer	0.00225	0.00318	CcSEcCtD
Cyclizine—Drowsiness—Epirubicin—ovarian cancer	0.00225	0.00318	CcSEcCtD
Cyclizine—Somnolence—Paclitaxel—ovarian cancer	0.00223	0.00315	CcSEcCtD
Cyclizine—Constipation—Paclitaxel—ovarian cancer	0.00215	0.00303	CcSEcCtD
Cyclizine—Pain—Paclitaxel—ovarian cancer	0.00215	0.00303	CcSEcCtD
Cyclizine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00213	0.00301	CcSEcCtD
Cyclizine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00213	0.003	CcSEcCtD
Cyclizine—Agranulocytosis—Epirubicin—ovarian cancer	0.0021	0.00297	CcSEcCtD
Cyclizine—Nervous system disorder—Docetaxel—ovarian cancer	0.00209	0.00295	CcSEcCtD
Cyclizine—Drowsiness—Doxorubicin—ovarian cancer	0.00208	0.00294	CcSEcCtD
Cyclizine—Tachycardia—Docetaxel—ovarian cancer	0.00208	0.00293	CcSEcCtD
Cyclizine—Skin disorder—Docetaxel—ovarian cancer	0.00207	0.00292	CcSEcCtD
Cyclizine—Hepatitis—Epirubicin—ovarian cancer	0.00202	0.00285	CcSEcCtD
Cyclizine—Urticaria—Paclitaxel—ovarian cancer	0.002	0.00282	CcSEcCtD
Cyclizine—Hypotension—Docetaxel—ovarian cancer	0.00199	0.00281	CcSEcCtD
Cyclizine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00199	0.0028	CcSEcCtD
Cyclizine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00197	0.00278	CcSEcCtD
Cyclizine—Agranulocytosis—Doxorubicin—ovarian cancer	0.00194	0.00274	CcSEcCtD
Cyclizine—Insomnia—Docetaxel—ovarian cancer	0.00193	0.00272	CcSEcCtD
Cyclizine—Paraesthesia—Docetaxel—ovarian cancer	0.00191	0.0027	CcSEcCtD
Cyclizine—Somnolence—Docetaxel—ovarian cancer	0.00189	0.00267	CcSEcCtD
Cyclizine—Eye disorder—Epirubicin—ovarian cancer	0.00189	0.00267	CcSEcCtD
Cyclizine—Hepatitis—Doxorubicin—ovarian cancer	0.00187	0.00264	CcSEcCtD
Cyclizine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00185	0.00261	CcSEcCtD
Cyclizine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00184	0.00259	CcSEcCtD
Cyclizine—Constipation—Docetaxel—ovarian cancer	0.00182	0.00257	CcSEcCtD
Cyclizine—Pain—Docetaxel—ovarian cancer	0.00182	0.00257	CcSEcCtD
Cyclizine—Chills—Epirubicin—ovarian cancer	0.00181	0.00256	CcSEcCtD
Cyclizine—Asthenia—Paclitaxel—ovarian cancer	0.0018	0.00254	CcSEcCtD
Cyclizine—Pruritus—Paclitaxel—ovarian cancer	0.00178	0.00251	CcSEcCtD
Cyclizine—Mental disorder—Epirubicin—ovarian cancer	0.00177	0.0025	CcSEcCtD
Cyclizine—Erythema—Epirubicin—ovarian cancer	0.00176	0.00248	CcSEcCtD
Cyclizine—Eye disorder—Doxorubicin—ovarian cancer	0.00175	0.00247	CcSEcCtD
Cyclizine—Tension—Epirubicin—ovarian cancer	0.00173	0.00244	CcSEcCtD
Cyclizine—Nervousness—Epirubicin—ovarian cancer	0.00171	0.00241	CcSEcCtD
Cyclizine—Muscle spasms—Epirubicin—ovarian cancer	0.00169	0.00239	CcSEcCtD
Cyclizine—Chills—Doxorubicin—ovarian cancer	0.00168	0.00237	CcSEcCtD
Cyclizine—Dizziness—Paclitaxel—ovarian cancer	0.00166	0.00234	CcSEcCtD
Cyclizine—Vision blurred—Epirubicin—ovarian cancer	0.00166	0.00234	CcSEcCtD
Cyclizine—Mental disorder—Doxorubicin—ovarian cancer	0.00164	0.00231	CcSEcCtD
Cyclizine—Erythema—Doxorubicin—ovarian cancer	0.00163	0.0023	CcSEcCtD
Cyclizine—Agitation—Epirubicin—ovarian cancer	0.00162	0.00228	CcSEcCtD
Cyclizine—Tension—Doxorubicin—ovarian cancer	0.0016	0.00225	CcSEcCtD
Cyclizine—Nervousness—Doxorubicin—ovarian cancer	0.00158	0.00223	CcSEcCtD
Cyclizine—Headache—Paclitaxel—ovarian cancer	0.00157	0.00222	CcSEcCtD
Cyclizine—Hypersensitivity—Docetaxel—ovarian cancer	0.00157	0.00221	CcSEcCtD
Cyclizine—Muscle spasms—Doxorubicin—ovarian cancer	0.00156	0.00221	CcSEcCtD
Cyclizine—Vision blurred—Doxorubicin—ovarian cancer	0.00153	0.00217	CcSEcCtD
Cyclizine—Asthenia—Docetaxel—ovarian cancer	0.00153	0.00216	CcSEcCtD
Cyclizine—Convulsion—Epirubicin—ovarian cancer	0.00152	0.00215	CcSEcCtD
Cyclizine—Hypertension—Epirubicin—ovarian cancer	0.00152	0.00214	CcSEcCtD
Cyclizine—Pruritus—Docetaxel—ovarian cancer	0.00151	0.00213	CcSEcCtD
Cyclizine—Agitation—Doxorubicin—ovarian cancer	0.0015	0.00211	CcSEcCtD
Cyclizine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00144	0.00203	CcSEcCtD
Cyclizine—Convulsion—Doxorubicin—ovarian cancer	0.00141	0.00199	CcSEcCtD
Cyclizine—Nervous system disorder—Epirubicin—ovarian cancer	0.00141	0.00199	CcSEcCtD
Cyclizine—Dizziness—Docetaxel—ovarian cancer	0.00141	0.00199	CcSEcCtD
Cyclizine—Hypertension—Doxorubicin—ovarian cancer	0.00141	0.00198	CcSEcCtD
Cyclizine—Tachycardia—Epirubicin—ovarian cancer	0.0014	0.00198	CcSEcCtD
Cyclizine—Skin disorder—Epirubicin—ovarian cancer	0.00139	0.00197	CcSEcCtD
Cyclizine—Hypotension—Epirubicin—ovarian cancer	0.00134	0.00189	CcSEcCtD
Cyclizine—Headache—Docetaxel—ovarian cancer	0.00133	0.00188	CcSEcCtD
Cyclizine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00133	0.00188	CcSEcCtD
Cyclizine—Nervous system disorder—Doxorubicin—ovarian cancer	0.0013	0.00184	CcSEcCtD
Cyclizine—Insomnia—Epirubicin—ovarian cancer	0.0013	0.00183	CcSEcCtD
Cyclizine—Tachycardia—Doxorubicin—ovarian cancer	0.0013	0.00183	CcSEcCtD
Cyclizine—Skin disorder—Doxorubicin—ovarian cancer	0.00129	0.00182	CcSEcCtD
Cyclizine—Paraesthesia—Epirubicin—ovarian cancer	0.00129	0.00182	CcSEcCtD
Cyclizine—Somnolence—Epirubicin—ovarian cancer	0.00128	0.0018	CcSEcCtD
Cyclizine—Hypotension—Doxorubicin—ovarian cancer	0.00124	0.00175	CcSEcCtD
Cyclizine—Pain—Epirubicin—ovarian cancer	0.00123	0.00173	CcSEcCtD
Cyclizine—Constipation—Epirubicin—ovarian cancer	0.00123	0.00173	CcSEcCtD
Cyclizine—Insomnia—Doxorubicin—ovarian cancer	0.0012	0.0017	CcSEcCtD
Cyclizine—Paraesthesia—Doxorubicin—ovarian cancer	0.00119	0.00168	CcSEcCtD
Cyclizine—Somnolence—Doxorubicin—ovarian cancer	0.00118	0.00167	CcSEcCtD
Cyclizine—Urticaria—Epirubicin—ovarian cancer	0.00114	0.00161	CcSEcCtD
Cyclizine—Constipation—Doxorubicin—ovarian cancer	0.00114	0.0016	CcSEcCtD
Cyclizine—Pain—Doxorubicin—ovarian cancer	0.00114	0.0016	CcSEcCtD
Cyclizine—Hypersensitivity—Epirubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Cyclizine—Urticaria—Doxorubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Cyclizine—Asthenia—Epirubicin—ovarian cancer	0.00103	0.00145	CcSEcCtD
Cyclizine—Pruritus—Epirubicin—ovarian cancer	0.00102	0.00143	CcSEcCtD
Cyclizine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000979	0.00138	CcSEcCtD
Cyclizine—Asthenia—Doxorubicin—ovarian cancer	0.000953	0.00135	CcSEcCtD
Cyclizine—Dizziness—Epirubicin—ovarian cancer	0.000949	0.00134	CcSEcCtD
Cyclizine—Pruritus—Doxorubicin—ovarian cancer	0.00094	0.00133	CcSEcCtD
Cyclizine—Headache—Epirubicin—ovarian cancer	0.000899	0.00127	CcSEcCtD
Cyclizine—Dizziness—Doxorubicin—ovarian cancer	0.000879	0.00124	CcSEcCtD
Cyclizine—Headache—Doxorubicin—ovarian cancer	0.000832	0.00117	CcSEcCtD
Cyclizine—Reboxetine—ABCB1—ovarian cancer	3.8e-05	0.319	CrCbGaD
Cyclizine—Clozapine—CYP1B1—ovarian cancer	3.48e-05	0.292	CrCbGaD
Cyclizine—Bepridil—ABCB1—ovarian cancer	1.89e-05	0.159	CrCbGaD
Cyclizine—Fentanyl—ABCB1—ovarian cancer	1.74e-05	0.146	CrCbGaD
Cyclizine—Clozapine—ABCB1—ovarian cancer	9.99e-06	0.0838	CrCbGaD
